PropertyValue
?:abstract
  • Since December 2019, a novel Coronavirus (SARS-CoV-2) was confirmed as the etiologic agent of a worldwide outbreak of a pneumonia that can result in severe respiratory failure. This clinical entity seems to be associated with a marked hypercoagulable state that causes both arterial and venous thromboembolic complications. Therefore, an adequate anti-thrombotic prophylaxis is recommended in hospitalized COVID-19 patients. Although rapidly worsening respiratory symptoms in a patient with SARS-CoV-2 respiratory infection may correlate with worsening pneumonia itself, it may also mask a pulmonary embolism. We report the case of a 50-year-old man affected by SARS-CoV-2 pneumonia, who developed acute pulmonary embolism. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11239-020-02160-1) contains supplementary material, which is available to authorized users.
?:creator
?:doi
  • 10.1007/s11239-020-02160-1
?:doi
?:journal
  • J_Thromb_Thrombolysis
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/f5d2284e3fbe5e0e48717042f4796e278ca1061c.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7260472.xml.json
?:pmcid
?:pmid
?:pmid
  • 32474757.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Acute pulmonary embolism in COVID-19 related hypercoagulability
?:type
?:year
  • 2020-05-30

Metadata

Anon_0  
expand all